» Articles » PMID: 28825675

Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway

Overview
Journal Nutrients
Date 2017 Aug 22
PMID 28825675
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial-to-mesenchymal transition (EMT) has received significant interest as a novel target in cancer prevention, metastasis, and resistance. The conversion of cells from an epithelial, adhesive state to a mesenchymal, motile state is one of the key events in the development of cancer metastasis. Polyphenols have been reported to be efficacious in the prevention of cancer and reversing cancer progression. Recently, the antimetastatic efficacy of polyphenols has been reported, thereby expanding the potential use of these compounds beyond chemoprevention. Polyphenols may affect EMT pathways, which are involved in cancer metastasis; for example, polyphenols increase the levels of epithelial markers, but downregulate the mesenchymal markers. Polyphenols also alter the level of expression and functionality of important proteins in other signaling pathways that control cellular mesenchymal characteristics. However, the specific proteins that are directly affected by polyphenols in these signaling pathways remain to be elucidated. The aim of this review is to analyze current evidence regarding the role of polyphenols in attenuating EMT-mediated cancer progression and metastasis. We also discuss the role of the most important polyphenol subclasses and members of the polyphenols in reversing metastasis and targeting EMT. Finally, limitations and future directions to improve our understanding in this field are discussed.

Citing Articles

Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms.

Singaravelan N, Tollefsbol T Nutrients. 2025; 17(4).

PMID: 40004944 PMC: 11858336. DOI: 10.3390/nu17040616.


Nutritional Dermatology: Optimizing Dietary Choices for Skin Health.

Assaf S, Kelly O Nutrients. 2025; 17(1.

PMID: 39796494 PMC: 11723311. DOI: 10.3390/nu17010060.


Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy.

El Oirdi M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931359 PMC: 11206774. DOI: 10.3390/ph17060692.


Influence of Hesperidin on the Physico-Chemical, Microbiological and Sensory Characteristics of Frozen Yogurt.

Cedillos R, Aleman R, Page R, Olson D, Boeneke C, Prinyawiwatkul W Foods. 2024; 13(5).

PMID: 38472921 PMC: 10931314. DOI: 10.3390/foods13050808.


A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics.

Purgatorio R, Boccarelli A, Pisani L, De Candia M, Catto M, Altomare C Antioxidants (Basel). 2024; 13(1).

PMID: 38275658 PMC: 10812703. DOI: 10.3390/antiox13010133.


References
1.
Orsulic S, Huber O, Aberle H, Arnold S, Kemler R . E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci. 1999; 112 ( Pt 8):1237-45. DOI: 10.1242/jcs.112.8.1237. View

2.
Eastman Q, Grosschedl R . Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol. 1999; 11(2):233-40. DOI: 10.1016/s0955-0674(99)80031-3. View

3.
Li D, Yee J, Thompson L, Yan L . Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett. 1999; 142(1):91-6. DOI: 10.1016/s0304-3835(99)00158-5. View

4.
Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R . Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999; 285(5435):1923-6. DOI: 10.1126/science.285.5435.1923. View

5.
Kahkonen M, Hopia A, Vuorela H, Rauha J, Pihlaja K, Kujala T . Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem. 1999; 47(10):3954-62. DOI: 10.1021/jf990146l. View